or Try an Advanced Search...

    Technical Analysis for AEON - AEON Biopharma, Inc.

    Grade Last Price % Change Price Change
    F 1.58 -3.07% -0.05
    AEON closed down 3.07 percent on Wednesday, May 15, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical AEON trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bullish Signal Line Cross Bullish -3.07%
    NR7 Range Contraction -3.07%
    Narrow Range Bar Range Contraction -3.07%
    Inside Day Range Contraction -3.07%
    Wide Bands Range Expansion -3.07%
    Older End-of-Day Signals for AEON ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 13 hours ago
    Down 3% about 13 hours ago
    Up 3% about 13 hours ago
    Fell Below Previous Day's Low about 13 hours ago
    Down 2 % about 13 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    AEON Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Botulinum Toxin Dystonia

    Is AEON a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 AEON Biopharma, Inc. (AEON) Loses -79.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
    May 9 AEON Biopharma Provides Update on Development Pipeline
    May 3 US Equity Markets Close Higher Friday Following Weak Jobs Report
    May 3 Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here Why
    May 3 AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
    Apr 19 Here's Why AEON Biopharma, Inc. (AEON) Is a Great 'Buy the Bottom' Stock Now
    Mar 31 CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants
    Mar 29 AEON Biopharma Announces Redemption of Public Warrants
    Mar 29 AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
    Mar 19 AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine
    See more AEON news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.17
    52 Week Low 1.38
    Average Volume 111,314
    200-Day Moving Average 6.87
    50-Day Moving Average 7.63
    20-Day Moving Average 3.16
    10-Day Moving Average 1.83
    Average True Range 0.66
    RSI (14) 24.24
    ADX 40.3
    +DI 13.45
    -DI 38.45
    Chandelier Exit (Long, 3 ATRs) 5.13
    Chandelier Exit (Short, 3 ATRs) 3.35
    Upper Bollinger Bands 6.15
    Lower Bollinger Band 0.18
    Percent B (%b) 0.23
    BandWidth 188.61
    MACD Line -1.70
    MACD Signal Line -1.78
    MACD Histogram 0.0781
    Fundamentals Value
    Market Cap 58.71 Million
    Num Shares 37.2 Million
    EPS -2.39
    Price-to-Earnings (P/E) Ratio -0.66
    Price-to-Sales 97.16
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.94
    Resistance 3 (R3) 1.93 1.81 1.88
    Resistance 2 (R2) 1.81 1.71 1.81 1.86
    Resistance 1 (R1) 1.69 1.66 1.63 1.70 1.84
    Pivot Point 1.57 1.57 1.54 1.57 1.57
    Support 1 (S1) 1.45 1.47 1.39 1.46 1.32
    Support 2 (S2) 1.33 1.42 1.33 1.30
    Support 3 (S3) 1.21 1.33 1.28
    Support 4 (S4) 1.22